Kelly Jones
Psychiatric/Mental Health · McCordsville, INNPI 1518546530
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,252 of the $9,469 with a category attached, or 87.1%. It is spread thinly across 28 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,382, 5.9 times the $573 reported in 2022. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 255 payments — averaging $37.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Johnson & Johnson$1K
- Alkermes, Inc.$1K
- Axsome Therapeutics, Inc.$769
- Otsuka America Pharmaceutical, Inc.$649
- plus $3K from 22 others
What the payments were for
- Travel & lodging$1,17012%
- Food & beverage$8,25287%
- Education$470%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 13 | $1,554 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 40 | $1,350 |
| Johnson & Johnson | 27 | $1,142 |
| Alkermes, Inc. | 39 | $1,119 |
| Axsome Therapeutics, Inc. | 25 | $769 |
| Otsuka America Pharmaceutical, Inc. | 15 | $649 |
| Neurocrine Biosciences, Inc. | 14 | $542 |
| Lundbeck LLC | 32 | $310 |
| AbbVie | 11 | $256 |
| Vanda Pharmaceuticals Inc. | 8 | $252 |
| Urgo Medical North America, LLC | 1 | $184 |
| E.r. Squibb & Sons, L.L.C. | 3 | $165 |
| Supernus Pharmaceuticals, Inc. | 3 | $157 |
| Teva Pharmaceuticals USA, Inc. | 2 | $148 |
| Cardiovascular Systems Inc. | 1 | $136 |
| Convatec Inc. | 1 | $124 |
| Corium, LLC | 3 | $122 |
| Gilead | 1 | $121 |
| Indivior Inc. | 6 | $105 |
| Braeburn Inc. | 1 | $76 |
| Terumo Medical Corporation | 1 | $53 |
| Tactile Systems Technology Inc | 2 | $30 |
| Smith+Nephew | 1 | $25 |
| Molnlycke Health Care US, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $15 |
| GSK | 1 | $15 |
| Medline Industries LP | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$4,308
- LYBALVI$1,800
- Kerecis GraftGuide$1,077
- CAPLYTA$906
- Auvelity$574
- Kerecis Omega3 SurgiClose$571
- INVEGA SUSTENNA$444
- INGREZZA$380
- SPRAVATO$362
- REXULTI$230
- Kerecis Omega3 GraftGuide$190
- Kerecis Omega3 Marigen$190
- VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP$184
- INVEGA TRINZA$169
- Diamondback Peripheral$136
- COBENFY$133
- UZEDY$127
- ABILIFY MAINTENA$126
- ABILIFY ASIMTUFII$126
- Fanapt$125
How this compares
$9,469 in reported general payments places this provider in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 110 | $281,778 |
| Invega TrinzaPaliperidone Palmitate | 11 | $98,991 |
| VraylarCariprazine Hcl | 42 | $61,190 |
| RexultiBrexpiprazole | 37 | $52,688 |
| TrintellixVortioxetine Hydrobromide | 91 | $43,346 |
| Abilify MaintenaAripiprazole | 14 | $40,606 |
| PerserisRisperidone | 15 | $34,430 |
| CaplytaLumateperone Tosylate | 14 | $23,167 |
| Paliperidone ErPaliperidone | 27 | $11,073 |
| Clozapine | 134 | $9,970 |
| BelsomraSuvorexant | 20 | $9,181 |
| Atomoxetine Hcl | 37 | $9,091 |
| Lurasidone Hcl | 106 | $8,586 |
| Ramelteon | 27 | $7,338 |
| Bupropion XlBupropion Hcl | 185 | $6,888 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $1,142 | $380,769121 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $649 | $93,29451 claims |
| AbbVieVraylar, Fetzima | $256 | $66,04353 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $16 | $49,134105 claims |
| Indivior Inc.Perseris | $105 | $34,43015 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,350 | $23,16714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in McCordsville
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
- Savannah MullinsClarksville$31K
- Sharon ClevengerFort Wayne$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.